The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 878 | 26,916 | SH | SOLE | 26,916 | 0 | 0 | ||
| ACHAOGEN INC | COM | 004449104 | 6,132 | 570,920 | SH | SOLE | 570,920 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 407 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 16,031 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
| ALMOST FAMILY INC | COM | 020409108 | 5,012 | 90,548 | SH | SOLE | 90,548 | 0 | 0 | ||
| AVEO PHARMACEUTICALS INC | COM | 053588109 | 2,951 | 1,057,690 | SH | SOLE | 1,057,690 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 2,534 | 301,349 | SH | SOLE | 301,349 | 0 | 0 | ||
| CENTENE CORP DEL | COM | 15135B101 | 7,162 | 71,000 | SH | SOLE | 71,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 6,846 | 1,478,519 | SH | SOLE | 1,478,519 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 11,206 | 1,647,879 | SH | SOLE | 997,879 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 2,720 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 952 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,790 | 31,198 | SH | SOLE | 31,198 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 9,469 | 678,793 | SH | SOLE | 678,793 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 3,509 | 655,815 | SH | SOLE | 655,815 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 4,575 | 171,352 | SH | SOLE | 171,352 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 4,055 | 506,852 | SH | SOLE | 506,852 | 0 | 0 | ||
| LIPOCINE INC NEW | COM | 53630X104 | 1,283 | 373,101 | SH | SOLE | 373,101 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 11,546 | 607,696 | SH | SOLE | 607,696 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 2,939 | 491,395 | SH | SOLE | 491,395 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 925 | 296,488 | SH | SOLE | 296,488 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 3,194 | 178,453 | SH | SOLE | 178,453 | 0 | 0 | ||
| QUOTIENT LTD | SHS | G73268107 | 4,616 | 932,523 | SH | SOLE | 932,523 | 0 | 0 | ||
| RADIUS HEALTH INC | COM NEW | 750469207 | 3,495 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 4,896 | 172,897 | SH | SOLE | 172,897 | 0 | 0 | ||
| SABRA HEALTH CARE REIT INC | COM | 78573L106 | 7,547 | 402,057 | SH | SOLE | 402,057 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 2,069 | 44,600 | SH | SOLE | 44,600 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 5,578 | 284,717 | SH | SOLE | 284,717 | 0 | 0 | ||
| ON ASSIGNMENT INC | PUT | 682159958 | 1,652 | 25,700 | SH | Put | SOLE | 25,700 | 0 | 0 | |